Brief: Eurobio Scientific Announces CE Mark For New Proprietary COVID-19 Test
14/04/2022 07:25
April 14 (Reuters) - Eurobio Scientific SA ALERS.PA :
* CE MARKING OF EUROBIO SCIENTIFIC'S NEW PROPRIETARY TEST
FOR THE
DETECTION OF OMICRON BA.X, BA.2 AND DELTA VARIANTS OF SARS-COV-2
* THE FIRST FRENCH CE-MARKED TEST FOR THE SCREENING OF
CURRENT
OMICRON AND DELTA VARIANTS REQUIRING ONLY ONE REACTION AND
DELIVERING A RESULT IN 45 MINUTES
Source text for Eikon: urn:newsml:reuters.com:*:nGNE3JtdG8
Further company coverage: ALERS.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Eurobio Scientific SA
See all newsBrief: Eurobio Scientific EB Development Files Public Offer For Shares
Brief: Eurobio Scientific Says At End Of June 2024, Recorded Revenues Of 73.4 Mln Euros, Compared With 59.1 Mln Euros A Year Ago
Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
Brief: Eurobio Scientific Cancels 694,300 Treasury Shares, Representing Around 6.34% Of Share Capital
Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million